The ASC Growth Explosion and Opportunities for the Medical Supply Chain
Growth in volume of procedures performed in Ambulatory Surgery Centers (ASCs) is accelerating, according to a study by Bain & Company — growth that’s being propelled by cost pressure, Medicare reimbursement of more ASC procedures, the rise of results-based care models, and physician and patient preference for outpatient surgery centers. The study noted that:
- In 2018, 5,700 ASCs operating in the United States performed 23 million procedures and generated $35 billion in revenue.
- Procedures performed at ASCs will grow by an average of 6% to 7% a year through 2021, up from 4% to 5% over the previous three years. Orthopedic, spine and cardio procedures will grow the fastest.
- By focusing on routine, lower-risk procedures in a more convenient setting, ASCs can offer surgical procedures at rates that are 35% to 50% lower than hospitals. That’s saving the U.S. healthcare system an estimated $40 billion a year and fueling ASC growth.1
Add the economic impact and risk concerns of the COVID-19 pandemic to all of this, and the shift to safer, lower cost of care settings is likely to occur even faster as hospitals: 1) seek to reduce the risk of exposure to the coronavirus and other hospital-acquired infections and 2) preserve their revenue line.
Suture Express Chief Commercial Officer Jason Pedaci has been keeping a close eye on the ASC market, especially since the onset of the coronavirus. With needs and demands unfolding in what seems like real time, he answers questions about what he’s seeing and learning about the potential impact on the medical supply chain for ASCs, not to mention what distributors need to do to respond.
Download the full Q&A article below to read more.
To learn more about what Suture Express may be able to do for you, visit us at sutureexpress.com or call 877-790-1873.
1"Ambulatory Surgery Center Growth Accelerates: Is Medtech Ready?”, Bain and Company, Sept. 23, 2019